Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.66 % |
3 Month Return | -16.95 % |
1 Year Return | + 52.94 % |
Market Stats | |
Previous Close | ₹125.26 |
Open | ₹124.79 |
Volume | 4.52L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹3,216.45Cr |
P/E Ratio | 10.37 |
PEG Ratio | 3.28 |
Market Cap | ₹3,216.45 Cr |
P/B Ratio | 2.66 |
EPS | 3.62 |
Dividend Yield | 2.87 |
Sector | Realty |
ROE | 11.34 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹3,216.45 Cr | 28.6% | 0.51 | ₹92 Cr | ₹157 Cr | |
NA | ₹50.26 Cr | -16.1% | 0.90 | -₹50 Cr | ₹27 Cr | |
NA | ₹31.25 Cr | -1.31% | 0.53 | NA | NA | |
BUY | ₹2,720.96 Cr | 11.21% | 0.80 | -₹68 Cr | ₹1,371 Cr | |
NA | ₹101.23 Cr | 3.85% | 0.54 | ₹5 Cr | ₹45 Cr |
Organisation | Alembic Ltd |
Headquarters | Vadodara |
Industry | Realty |
E-voting on shares | Click here to vote |
Key events for Alembic Ltd
Alembic Ltd reported a 64.03% increase in net sales to Rs 51.10 crore for September 2024, with net profit rising 48.92% to Rs 76.60 crore. EBITDA also grew by 46.09%. The EPS increased to Rs 2.98. Alembic shares have shown significant returns of 26.30% over the last 6 months and 55.51% over the last year.
Alembic Pharmaceuticals Secures USFDA Approval and Reports Growth - 11 Nov, 2024
Alembic Pharmaceuticals received USFDA approval for Diltiazem Hydrochloride capsules, indicated for hypertension. The company also reported significant growth in net sales and profits for September 2024.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 1.42% to 1.96% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 55.82 Cr → 121.02 Cr (in ₹), with an average increase of 53.9% per quarter
Revenue Rich
Revenue is up for the last 4 quarters, 41.55 Cr → 118.51 Cr (in ₹), with an average increase of 25.8% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 5.6%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 103.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.88% of holdings in Sep 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 27.64% to 27.06% in Sep 2024 quarter
Price Dip
In the last 3 months, ALEMBICLTD stock has moved down by -17.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 70.88% | 0.00 | |
Foreign Institutions | 1.96% | 38.01 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.06% | ||
Others | 0.09% | 75.05 |
Alembic Ltd in the last 5 years
Lowest (2.82x)
March 31, 2020
Today (10.37x)
November 19, 2024
Industry (129.60x)
November 19, 2024
Highest (15.06x)
August 23, 2024
Alembic Ltd’s net profit jumped 33.46% since last year same period to ₹121.02Cr in the Q2 2024-2025. On a quarterly growth basis, Alembic Ltd has generated 116.8% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Alembic Ltd has declared dividend of ₹2.40 - translating a dividend yield of 1.92%.
Read More about DividendsBearish
Neutral
Bullish
Alembic Ltd is currently in a Bearish trading position according to technical analysis indicators.
Alembic Ltd (ALEMBICLTD) share price today is ₹123.26
Alembic Ltd is listed on NSE
Alembic Ltd is listed on BSE
PE Ratio of Alembic Ltd is 10.37
PE ratio = Alembic Ltd Market price per share / Alembic Ltd Earnings per share
Today’s traded volume of Alembic Ltd(ALEMBICLTD) is 4.52L.
Today’s market capitalisation of Alembic Ltd(ALEMBICLTD) is ₹3216.45Cr.
Alembic Ltd(ALEMBICLTD | Price |
---|---|
52 Week High | ₹169 |
52 Week Low | ₹78.1 |
Alembic Ltd(ALEMBICLTD) share price is ₹123.26. It is down -27.07% from its 52 Week High price of ₹169
Alembic Ltd(ALEMBICLTD) share price is ₹123.26. It is up 57.82% from its 52 Week Low price of ₹78.1
Alembic Ltd(ALEMBICLTD | Returns |
---|---|
1 Day Returns | -2% |
1 Month Returns | -1.66% |
3 Month Returns | -16.95% |
1 Year Returns | 52.94% |